Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06502717 · ClinicalTrials.gov registry record · NA
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders
A NA study of Depression and Anxiety, sponsored by Viome.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06502717: Recruiting NA study of Depression and Anxiety, sponsored by Viome.
NCT06502717 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Viome. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06502717, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Viome.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites.
Conditions Studied
Interventions
- COMBINATION_PRODUCT VIOME Precision Nutrition Program
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06502717 shows while recruiting
NCT06502717 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which VIOME Precision Nutrition Program is the first listed.
NCT06502717 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06502717 about?
NCT06502717 is a clinical study titled "Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders". US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites.
What is the current status of trial NCT06502717?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-07-08. Estimated completion is 2025-12.
What conditions does trial NCT06502717 study?
This clinical trial studies the following conditions: Depression, Anxiety, Mental Health Issue.
What interventions are being tested in trial NCT06502717?
The interventions under investigation include: VIOME Precision Nutrition Program (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06502717?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06502717 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06502717's enrollment target sits among peer trials
150 249th of 679 higher than 416 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy